Company / Total Assets
Enovis Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.8B
FY2025
5-year range
$3.8B / $8.5B
FY2021-FY2025
Trend
-18.7%
vs FY2024
Sector context
#67 of 161
Health Care
What the data says
At $3.8B, Enovis's total assets ranks #67 of 161 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $3.8B in FY2025 to $8.5B in FY2021.
Based on SEC 10-K filings.
$3.8B in FY2025 with a 5-year CAGR of -12.2%.
Declined from $4.5B to $3.8B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.5%
- 5-Year CAGR
- -12.2%
- 10-Year CAGR
- -
Sector benchmark
#67 of 161 in Health CareTop 42% of 161This company $3.8B Sector average $14.8B
▼
-74.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -12.2%, indicating a declining trend.
- In FY2025, total assets decreased 18.7% year-over-year.
- Ranks #67 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.8B | -18.7% |
| FY2024 | $4.7B | +4.6% |
| FY2023 | $4.5B | +5.5% |
| FY2022 | $4.3B | -49.8% |
| FY2021 | $8.5B | +15.8% |
| FY2020 | $7.4B | -0.5% |
| FY2019 | $7.4B | +11.7% |
| FY2018 | $6.6B | -1.4% |
| FY2017 | $6.7B | +5.9% |
| FY2016 | $6.3B | -5.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026